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ReseaRch aRticle 
INtRODUctiON
Cerebral hypoxia-ischemia injury is a significant source of 
morbidity and mortality in cardiac arrest survivors.1 Cardiac 
arrest disrupts global cerebral circulation, leading to neuronal 
damage in multiple brain regions including the hippocampus, 
cortex, cerebellum, thalamus, prefrontal cortex, and putamen.2,3 
The Cornu Ammonis 1 (CA1) region of the hippocampus is 
particularly sensitive to cerebral ischemia and CA1 neuronal 
degeneration results in hippocampus dysfunction.4-6 Cardiac 
arrest survivors commonly experience cognitive deficits in 
memory and executive function.1,3,7,8
Emerging evidence has demonstrated that low concentration 
hydrogen gas (up to 3%) or hydrogen-rich saline attenuates 
hippocampal neuronal injury in animal models of global brain 
ischemia9-11 due to unique antioxidative and antiapoptotic prop-
erties. The safety of hydrogen gas therapy at this concentration 
was reported in several cases of patients with post-resuscitation 
syndromes.12 It may serves as a novel translational therapeutic 
approach in addition to neuroprotection strategies previously 
reported in the setting of experimental ischemic stroke.13-16 Re-
cently, water-electrolysis derived high concentration hydrogen 
gas has been shown in rats to provide similar neuroprotection 
against focal brain and retina ischemia-reperfusion injury 
without systemic adverse effects.17,18 We previously reported 
a tendency toward improvement in short-term neurological 
deficit scores provided by 67% hydrogen gas in a rat model of 
asphyxia-induced cardiac arrest (ACA).19 In the present study, 
we further investigated the efficacy of this 67% hydrogen gas 
in improving cognitive outcomes in global brain hypoxia-
ischemia induced by ACA in rats. 
MateRials aND MethODs
All protocols were approved by the Animal Health and 
Safety Committees of Loma Linda University, USA (approval 
number: IACUC #8170006) on March 2, 2017) and were in 
compliance with Federal regulations. 
animal model and groups
A total of 44 male Sprague-Dawley rats (9 months old, body 
weight 450–550 g) were investigated in the following groups: 
sham (n = 6), ACA (n = 13), ACA + hydrogen post-treatment 
(n = 13), ACA + hydrogen pre- & post-treatment (n = 12) 
groups. ACA was induced as previously described.19 Briefly, 
rats were anesthetized with pentobarbital (45 mg/kg; Virbac 
AH, Inc., Fort Worth, TX, USA) and the trachea was orally 
intubated with a 14-gauge plastic catheter. For monitoring 
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arterial pressure and administration of resuscitation drugs, two 
PE 50 catheters (Becton Dickinson, Franklin Lakes, NJ, USA) 
were inserted into the left femoral artery and vein until reaching 
the abdominal aorta and the inferior vena cava, respectively. 
Electrocardiogram (Lead II) was continually recorded. The 
animals were mechanically ventilated with room air at a rate 
of 100 breaths/min at a tidal volume of 0.55 mL/100 g for 15 
minutes. Asphyxia resulted from intravenous injection of a 
chemical neuromuscular blockade (vecuronium 2 mg/kg in-
travenously injected, Mylan Institutional LLC., Rockford, IL, 
USA) followed by ventilator disconnection and endotracheal 
tube obstruction. After 9 minutes of asphyxia, precordial com-
pression was started using a pneumatically driven mechanical 
chest compressor coincident mechanically ventilation (100% 
oxygen) at ratio of 2:1. At the start of precordial compression, 
a bolus dose of epinephrine (7.5 μg/kg, International medica-
tion system, LLC., South El Monte, CA, USA) with sodium 
bicarbonate (1 mEq/kg, Hospira, Lake Forest, IL, USA) was 
injected into the left femoral vein. Resuscitation or return of 
spontaneous circulation (ROSC) was defined as the return 
of supraventriclar rhythm with mean artery pressure over 
60 mmHg (1 mmHg = 0.1333 kPa) for 5 minutes. 
After resuscitation, mechanical ventilation support was 
continued, and then stopped 1 hour after ROSC. All catheters 
including endotracheal tube were removed. Animals were 
closely observed by the investigator for an additional 2 hours. 
Body temperature was monitored through a rectal temperature 
sensor (Model BAT-12, Physitemp instrument Inc., Clifton, 
NJ, USA) and maintained at 36.8 ± 0.2°C. 
Lead II electrocardiogram, end-tidal carbon dioxide and arte-
rial pressure were continuously recorded beginning 15 minutes 
before asphyxia induction and continuing to 1 hour after ROSC 
using a precordial compression-based data-acquisition system 
supported by WINDAQ software (DATAQ, Akron, OH, USA).
hydrogen treatment 
Hydrogen was delivered through a hydrogen treatment 
chamber with the inlet connected to a hydrogen nebulizer 
(AMS-H-01; Asclepius Meditec Co. Ltd., Shanghai, China) 
that produced a 67% hydrogen and 33% oxygen gas mixture. 
The hydrogen concentration was monitored by a hydrogen 
detector during the administration. Hydrogen was adminis-
tered starting at 1 hour prior to cardiac arrest for 1 hour and 
then restarted at 1 hour post-resuscitation for 1 hour (pre- & 
post-treatment group) or starting at 1 hour post-resuscitation 
for 2 hours (post-treatment).
cognitive function evaluation
Both T-maze and water maze are tests of cognitive function. 
The water-maze is a more comprehensive test of cognitive 
function but requires the rats to swim. At 7 days post-resus-
citation, ACA rats did not have sufficient motor strength to 
swim, which would confound cognitive assessments. Thus 
at 7 days post-resuscitation, T-maze for spontaneous alterna-
tion was used to examine exploratory behavior and working 
memory of the hippocampus as previously described.20 Briefly, 
rats were placed in a T-shaped maze and allowed to freely 
explore the two arms of the maze throughout 10-trials. The 
spontaneous alternation rate was calculated as the percentage 
of the alternating choices out of 10 trials.
Starting on day 14 post-resuscitation, Morris water maze test 
was used to assess the learning and spatial memory function of 
rats as previously described.20 This four-day test consisted of 
both cued and hidden tests with test duration up to 60 seconds 
per trial. The activities and the swim paths of the rats were 
recorded by a video recording system. The total distance of 
swimming, latency, and swimming speed were measured by 
the Video Tracking System SMART-2000 (San Diego Instru-
ments Inc., San Diego, CA, USA). 
Fluoro-Jade c staining
ACA rats were sacrificed after completion of testing at either 
7 days (n = 6/group) or 18 days post-resuscitation (n = 6/
group), and sham rats (n = 6) were sacrificed on day 18 by 
deep anesthesia using 5% isoflurane followed by transcardial 
perfusion with 10% formaline. Brain frozen coronal slices 
(10 μm) at the level of the hippocampus were sectioned in 
a cryostat (CM3050S; Leica Microsystems, Buffalo Grove, 
IL, USA).
Neuronal degeneration was evaluated by Fluoro-Jade C 
staining kit (Millipore, Temecula, CA, USA) as previously 
described.21 Based on the manufacturer’s instructions, slices 
were incubated in 1% sodium hydroxide solution for 5 min-
utes, followed by 2-minute rinses with 70% ethanol then dis-
tilled water. Subsequently, the slices were incubated in 0.06% 
potassium permanganate solution for 10 minutes. Following 
2-minute rinse in distilled water, the slices were incubated 
with 0.0001% solution of Fluoro-Jade C which was dissolved 
in 0.1% acetic acid. Then the slices were rinsed with distilled 
water 3 times for 1 minute each time. Slides were dried for 
5 minutes, and then immersed in xylene for 1 minute, and 
then a cover slip with DPX (Sigma-Aldrich, St. Louis, MO, 
USA) was placed. The sections were reviewed using a Leica 
DMi8 fluorescence microscope (Leica Microsystems, Buf-
falo Grove, IL, USA). Image J software (ImageJ 1.5, NIH, 
Bethesda, MD, USA) was used to evaluate the numbers of 
Fluoro-Jade C positive neurons within CA1 regions (averaged 
from three fields of views for each rat). 
statistical analysis
Quantitative data were presented as the mean ± standard error 
of mean (SEM). SigmaPlot 11.0 (Systat Software, Inc., San 
Jose, CA, USA) was used for statistical analysis. One-way 
analysis of variance was applied for multiple comparisons 
followed by Student-Newman-Keuls post hoc test. A P value 
less than 0.05 was considered statistically significant. 
ResUlts
All animals survived the pre-ACA surgical procedure. One rat 
in ACA and one rat in ACA + hydrogen post-treatment groups 
could not be resuscitated. 
hydrogen treatment does not affect the hemodynamic param-
eters in rats with asphyxia induced-cardiac arrest
There were no significant differences in baseline and post-
resuscitation values of heart rate, mean arterial pressure and 
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end-tidal carbon dioxide among ACA, ACA + hydrogen post-
treatment and ACA + hydrogen pre- & post-treatment groups 
(P > 0.05; data not shown). 
hydrogen treatment improves cognitive function of rats with 
asphyxia induced-cardiac arrest 
T-maze
At 7 days after resuscitation, the ACA rats had significantly 
worse performance in T-maze test than shams (P = 0.025). 
Although there was not statistical difference (hydrogen 
post-treatment + ACA vs. ACA: P = 0.345; hydrogen pre- & 
post-treatment +ACA vs. ACA: P = 0.295), both hydrogen 
gas treatment regimens tended to improve the percentage 
of spontaneous alternations, suggesting better exploratory 
behavior and working memory (Figure 1). 
Morris water maze
Starting at 14 days after resuscitation, the Morris water maze 
test showed memory-learning deficits in ACA rats. On the 
4th day of testing (18 days after resuscitation), ACA rats had 
significantly longer total swimming distances than shams (P = 
0.012) before reaching the platform placed in the water. In the 
probe test in which the platform was removed from the south-
west quadrant, ACA rats spent significantly lesser time in the 
southwest quadrant, suggesting spatial memory dysfunction 
(P = 0.005). Hydrogen treatments significantly shortened the 
total swimming distance in comparison to ACA rats (P = 0.025, 
ACA + hydrogen post-treatment vs. ACA; P = 0.01, ACA + 
hydrogen pre- & post-treatment vs. ACA; Figure 2). There was 
no significant difference in swimming speed among groups, 
suggesting the comparable motor function (data not shown). 
hydrogen treatment does increased the neuronal survival in 
the hippocampal ca1 region of rats with asphyxia 
induced-cardiac arrest 
Correlating with the functional outcomes, Fluoro-Jade C 
staining showed: 1) elevated neuron death at day 7 (P = 0.016, 
vs. sham group) and day 18 (P = 0.013, vs. sham group) post-
resuscitation within hippocampal CA1 regions in animals 
subjected to ACA; 2) hydrogen gas treatment improved neu-
ronal survival at 7 days, reaching statistical significance at 18 
days (P = 0.027, ACA + hydrogen post-treatment vs. ACA; 
P = 0.016, ACA + hydrogen pre- & post-treatment vs. ACA) 
after resuscitation (Figure 3). 
DiscUssiON
Using a rat model of asphyxia induced-cardiac arrest, we 
demonstrated that 67% hydrogen gas administered either as 
pre- & post-treatment or post-treatment resulted in improved 
spatial learning function, which was associated with better 
neuronal survival within hippocampal CA1 regions. 
Complex pathophysiologic mechanisms underlie global 
brain injury following cardiac arrest and cardiopulmonary-
cerebral resuscitation, in which neuronal apoptosis is one of 
the important pathologic changes.22 The hippocampal CA1 
region has been shown to be highly vulnerable to hypoxia-
ischemia.4,5 In the present study, asphyxia induced-cardiac 
arrest resulted in global brain injury with significant degenera-
Figure 1: Effect of hydrogen (H2) treatment on the T-maze test of rats with 
asphyxia induced-cardiac arrest (ACA) at 7 days post-resusciation. 
Note: Rats subjected to ACA had significantly lower rates of spontaneous alteration 
between the right and left arms than shams. There was a tendency toward improved 
T-maze performance in ACA rats that received hydrogen gas pre&post-treatment. 
Data were presented as the  mean ± SEM (n = 6/group). *P < 0.05, vs. sham group 
(one-way analysis of variance followed by Student-Newman-Keuls post hoc test). 
Figure 2: Effect of hydrogen (H2) treatment on the Morris water maze test of rats with asphyxia induced-cardiac arrest (ACA) starting at 14 days post-resuscitation.
Note: (A) Swimming distance. There were signficant longer swimming distances in rats subjected to ACA at the 4th day of spatial learning testing. H2 treatment significantly 
shortened the total swimming distance. (B) Latency. Probe test showed that rats subjected to ACA spent significantly lesser time than shams in the quadrant where the 
platform was placed during spatial learning testing. This effect was diminished by H2 treatments. Data were presented as the  mean ± SEM (n = 6/group). *P < 0.05, vs. 
sham group; #P < 0.05, vs. ACA group (one-way analysis of variance followed by Student-Newman-Keuls post hoc test). 
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tion of neurons within hippocampal CA1 regions at 7 and 18 
days post-resuscitation. This neuronal damage was associated 
with hippocampal dysfunction as detected by T-maze and water 
maze test. The retired breeder rats used in this study were 8–12 
months of age and our findings are consistent to previous report 
by Cohan et al.23 In their study, 9-month-old rats demonstrated 
significant spatial memory impairment and hippocampal CA1 
neuron reduction following asphyxia cardiac arrest.23
Oxidative stress causes lipid peroxidation and DNA 
oxidation, contributing to neuronal apoptosis in the setting of 
ischemia.24 Low concentration hydrogen gas inhalation at the 
start of CPR provided similar neuroprotection to therapeutic 
hypothermia and resulted in additive effects through its unique 
antioxidant features when applied with hypothermia in a rat 
model of ventricular fibrillation cardiac arrest.25,26 Hydrogen-
rich saline also reduced the hippocampal tissue damage in-
duced by global cerebral ischemia/reperfusion via protection 
of mitochondrial function.27 In 2016, Cui et al.17 demonstrated 
the neuroprotective efficacy of water electrolysis derived 67% 
hydrogen inhalation in a rat model of focal brain ischemia. 
Two hours of high concentration hydrogen treatment decreased 
brain reactive oxygen species levels, neuronal apoptosis and 
neuroinflammation within the cerebral cortex and hippocam-
pus in the absence of systemic toxicity.17 In the present study, a 
modified T-maze used as a quick test of hippocampal function 
at 7 days after resuscitation showed water-electrolysis 67% 
hydrogen tended to improve exploratory behavior although 
this was not statistically significant. The improved functional 
outcome correlated with a tendency toward increased hip-
pocampal CA1 neuron survival at 7 days post-resuscitation. 
Over 4 days beginning 14 days after resuscitation, rats treated 
with 67% hydrogen had significant improvement of hippo-
campal spatial learning memory as tested by water maze, a 
comprehensive behavioral test. Significantly less hippocampal 
CA1 neuron degeneration was associated with this cognitive 
improvement. Activation of the phosphoinositide 3-kinase/
Akt pathway has been shown to play a role in the protective 
effects of 67% hydrogen gas in a rat model of liver ischemia-
reperfusion.28 Because of the importance phosphoinositide 
3-kinase/Akt signaling in neuronal survival,29 we speculate 
that a similar mechanism of protection would underlie the 
hippocampal neuron protection provided by high concentration 
hydrogen. Nevertheless, molecular hydrogen has been shown 
to activate a variety of signaling pathways contributing to its 
neuroprotection.30
Human clinical studies of therapeutic hydrogen gas admin-
istration have been undertaken in Japan in 2017.12,31,32 The 
feasibility and safety of 2% hydrogen for patients with post 
cardiac arrest syndrome have been validated in a pilot clinical 
study.33 A multicenter randomized trial to confirm the efficacy 
of low concentration hydrogen gas inhalation on neurological 
outcomes in comatose survivors of out-of-hospital cardiac 
arrest is underway.12 Additionally, 3% hydrogen inhalation 
administered to patients 1 hour twice a day for 7 days follow-
ing mild ischemic stroke significantly improved both MRI and 
neurological outcomes.32
If the dose dependent effects of molecular hydrogen therapy 
that have been demonstrated in animal studies34,35 translate to 
human neurological outcomes, then water electrolysis would 
be a safe way to generate high concentration hydrogen gas and 
would be feasible to use in clinical management of cardiac 
arrest survivors. 
There are several limitations in the study. We only evaluated 
the cognitive benefits of hydrogen up to 18 days after ACA. 
Future study is necessary to confirm our finding at longer 
time points. In this study, we demonstrated cognitive benefits 
associated with the improved the neuron survival following hy-
drogen administration after resuscitation from ACA. However, 
mechanisms of neuroprotective effects potentially provided 
by high-concentration hydrogen need to be further elucidated. 
In conclusion, our study suggests that high concentration 
hydrogen derived by water electrolysis could be a promising 
therapeutic strategy to decrease cognitive deficits in the setting 
of cardiac arrest.
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